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Abstract
Background—Intrauterine device (IUD) insertion during menses may be viewed as preferable 
by some providers, as it provides reassurance that the woman is not pregnant. However, this 
practice may result in unnecessary inconvenience and cost to women. The objective of this 
systematic review is to evaluate the evidence for the effect of inserting IUDs on different days of 
the menstrual cycle on contraceptive continuation, effectiveness and safety.
Study Design—We searched the MEDLINE database for peer-reviewed articles published in 
any language from database inception through March 2012 concerning the effect of inserting 
copper IUDs (Cu-IUD) or levonorgestrel-releasing IUDs (LNG-IUDs) on different days of the 
menstrual cycle on contraceptive continuation, effectiveness, and safety. The quality of each 
individual piece of evidence was assessed using the United States Preventive Services Task Force 
grading system.
Results—We identified eight articles that met the criteria for review. Each study examined the 
Cu-IUD; no studies were identified that examined the LNG-IUD. Overall, these studies suggest 
that timing of Cu-IUD insertion has little effect on longer term outcomes (rates of continuation, 
removal, expulsion, or pregnancy) or on shorter term outcomes (pain at insertion, bleeding at 
insertion, immediate expulsion). Specifically, there was no evidence to suggest that outcomes 
were better when Cu-IUD insertions were performed during menses. Limitations of the studies 
include small sample sizes for insertions performed during later days of the menstrual cycle and 
non-randomized assignment to timing of insertion.
Conclusions—There is fair evidence (body of evidence grading: II-2, fair) indicating that timing 
of Cu-IUD insertion has little effect on contraceptive continuation, effectiveness or safety.
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Intrauterine device (IUD) insertion during menses may be viewed as preferable by some 
providers, as it provides reassurance that the woman is not pregnant. However, for women 
seeking IUD insertion during other times in the menstrual cycle, this practice may result in 
unnecessary inconvenience and cost. Issues to consider when making recommendations 
regarding when during the menstrual cycle (i.e., not postpartum or postabortion) a woman 
can start IUD use include making sure the woman is not pregnant and whether IUD insertion 
at different times during the menstrual cycle has different effects on contraceptive 
continuation, effectiveness or safety. A list of criteria has been developed by the World 
Health Organization to guide the provider in determining whether a woman is pregnant [1]. 
This review examines the evidence for inserting IUDs at different times during the 
menstrual cycle with regard to pain, bleeding, expulsion, and contraceptive effectiveness.
2. Materials and methods
We searched the MEDLINE database for peer-reviewed articles published in any language 
from database inception through March 2012 concerning the effect of inserting IUDs at 
different times during the menstrual cycle with regard to pain, bleeding, continuation, 
expulsion and pregnancy risk using the following search strategy:
(levonorgestrel AND (intrauterine devices[mesh] OR iud OR iucd OR ius OR 
intrauterine system OR intra-uterine system OR intrauterine device OR intra-
uterine device)) OR Mirena OR (copper IUD OR Paragard OR Nova T OR 
intrauterine device OR copper releasing IUD) AND (insert* AND (cycle OR 
menstruat*)) AND (“bleeding” OR pain OR expulsion OR continuation OR 
pregnancy) Limits: Humans
Additionally, the Cochrane Library was searched for any systematic reviews on this topic. 
We also hand-searched reference lists from articles identified by the search and key review 
articles to identify any additional articles.
2.1. Study selection
We reviewed titles as well as abstracts to identify studies investigating the effects of 
inserting IUDs at different times during the menstrual cycle on pain, bleeding, continuation, 
expulsion and pregnancy risk. We excluded studies that examined IUDs other than copper 
IUDs (Cu-IUDs) or levonorgestrel-releasing IUDs (LNG-IUDs).
2.2. Study quality assessment
The evidence was summarized and systematically assessed through the use of standard 
abstract forms [2]. The quality of each individual piece of evidence was assessed using the 
United States Preventive Services Task Force grading system [3].
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We did not compute summary measures of association due to heterogeneity across the 
identified studies with respect to the manner in which outcomes were reported, study design, 
study population and lengths of follow-up.
3. Results
The search strategy identified a total of 391 articles. After reviewing the titles and abstracts 
of these articles, as well as the full articles when necessary, eight articles met our criteria for 
inclusion in this review (Table 1) [4–11]. No systematic reviews were found from the search 
of the Cochrane database. Each of the eight studies included in this review examined the Cu-
IUD. We did not identify studies examining the timing of insertion of the LNG-IUD.
Four cohort studies examined the effects of Cu-IUD insertion at different times during the 
menstrual cycle on rates of continuation, removal, expulsion, and/or pregnancy [4,5,9,10]. A 
study of 9904 women found that rates of expulsion in the first two months post-insertion 
were highest among women with insertions on Cycle Days 1–5 (50.3 per 1000), with rates 
decreasing to 30.5 for insertion on Cycle Days 6–10, 24.0 for insertion on Cycle Days 11–17 
and 22.0 for insertions on Cycle Day 18 or later (p<.0001 for trend) [10]. However, 
removals for pain and bleeding increased as day of the cycle increased, primarily for 
insertions after Day 17; removal rates were 20.9 per 1000 for Cycle Days 1–5 and 20.6 per 
1000 for Cycle Days 6–10, increasing to 27.2 for Cycle Days 11–17 and to 36.7 per 1000 for 
Cycle Day 18 and later (p for trend=0.01). Risk of pregnancy also increased with increasing 
cycle day of insertion, but the trend did not reach statistical significance (p=.13). The 
authors estimated from these data that there would be nine excess IUD discontinuations per 
every 1000 insertions before Cycle Day 11 due to expulsion, pain and bleeding, or 
pregnancy than if insertions were done after Cycle Day 11. There were no observed trends 
for rates of expulsions, removals for pain and bleeding or pregnancy during the third and 
fourth months post-insertion.
A second study examined a cohort of 2536 women and found that continuation rates were 
highest among those who underwent insertion during menses or immediately thereafter [4]. 
Continuation at 12 months was 92.0% for insertion during Cycle Days 1–3, 89.3% for Cycle 
Days 4–7, 87.8% for Cycle Days 8–14, 88.3% for Cycle Days 15–21 and 84.8% for Cycle 
Days ≥22; no statistical comparison was reported. Total removals as well as removals for 
bleeding and pain and for infection were highest among those with insertions on Cycle Days 
≥22. Expulsion rates were highest among those with insertions on Cycle Days 8–14 (3.2%), 
compared with those with insertions on Cycle Days 1–3 (1.6%), Cycle Days 4–7 (1.9%), 
Cycle Days 15–21 (1.1%), or Cycle Days ≥22 (1.2%), although no statistical comparison 
was reported. Pregnancy rates did not differ by timing of insertion (p>.05).
A third cohort study examined 867 women with IUD insertions occurring during or after 
menses and found that over 12 months, rates of continuation, expulsion, removal and 
pregnancy did not differ by timing of insertion (p>.10) [5]. A fourth cohort study examined 
615 women, including 156 HIV-positive women and 493 HIV-negative women, and found 
that over four months, those with insertions during menses had similar rates of expulsion, 
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removal and pelvic inflammatory disease (PID) as those with insertions outside the menses, 
although direct statistical comparisons were not reported [9]. There were no pregnancies in 
either group. The odds for any IUD complication did not significantly differ among those 
with insertions outside menses versus during menses [adjusted odds ratio (OR)= 1.65, 95% 
confidence interval (CI) 0.21–12.91].
A nested case-control identified for this review also examined the association between IUD 
expulsion and timing of IUD insertion [11]. Among participants of a clinical trial examining 
different types of Cu-IUDs, 70 women who experienced an IUD expulsion during the trial's 
12-month follow-up period were classified as cases and 1536 women with an IUD in place 
at their last study visit were classified as controls. The odds for expulsion did not differ 
among those with insertions outside menses compared to those with insertions during 
menses (unadjusted OR=0.8, 95% CI 0.5–1.5).
Four studies [6–9] examined the effects of timing of IUD insertion on insertion problems, 
including pain, bleeding, and/or immediate expulsion. A subgroup analysis of 29 nulliparous 
women enrolled in a clinical trial of an analgesic agent reported that the pain index (total 
amount of pain, discomfort and bleeding over 7 days post-insertion) was positively 
correlated with the day of the cycle on which the IUD was inserted (Spearmen rs=0.4559) 
[6]. A second study of 84 nulliparous women reported that immediate pain following IUD 
insertion was independent of day of cycle [7]. Further description of these results is lacking 
in both studies. A subgroup analysis of women enrolled in a clinical trial of prophylactic 
ibuprofen at IUD insertion found pain after insertion measured by a visual analog scale was 
highest among those with insertions <6 days or ≥11 days since the start of last menstrual 
period and lowest among those with insertions 6–10 days since the start of last menstrual 
period (p<.05 non-parametric Kruskal-Wallis test) [8]. Another study identified for this 
review was a baseline assessment of 1667 women undergoing IUD insertion, of whom some 
were selected for follow-up in a cohort study already described [9]. This study found that 
pain at the time of IUD insertion was more common among those with insertions outside 
menses than during menses (2.1% vs. 0%) and that rates of bleeding at the time of insertion 
were similar (1.6% vs. 1.8%), although no direct statistical comparisons were reported. 
Immediate expulsion (not further defined) was more common among those with insertions 
during menses (7.0%) than those with insertions outside of menses (2.8%). A statistical 
comparison of immediate expulsions that also included a third group of women with 
oligomenorrhea/amenorrhea (1.7%) was statistically significant (p<.05). The odds for any 
IUD insertion problem among those with insertions outside versus within menses was non-
significant (adjusted OR=0.54, 95% CI 0.18–1.59).
4. Discussion
Overall, the eight studies included in this review suggest that timing of Cu-IUD insertion has 
little effect on longer term outcomes (rates of continuation, removal, expulsion or 
pregnancy) or on shorter term outcomes (pain at insertion, bleeding at insertion, immediate 
expulsion). Rates of expulsion and rates of removal in relation to timing of Cu-IUD insertion 
were examined in four prospective cohort studies [4,5,9,10], while one nested case-control 
study examined the association between IUD expulsion and timing of IUD insertion [11]. 
Whiteman et al. Page 4













These studies found little evidence that expulsion rates or removal rates varied by timing of 
insertion during the menstrual cycle or specifically that rates were lower when insertions 
were performed during menses. Additionally, two prospective cohort studies provided 
evidence on continuation rates over 12 months by timing of IUD insertion. In one, 
continuation rates were highest among those with insertion during menses or immediately 
thereafter [4]; however, no statistical comparison was reported. In the other, rate of 
continuation did not differ by timing of insertion [5]. In each of the reviewed studies, the 
majority of women underwent IUD insertion during or soon after menses, which may have 
limited their power to examine insertions later in the menstrual cycle.
Three large, prospective cohort studies examined pregnancy rates associated with Cu-IUD 
insertions during different times of the menstrual cycle and found little evidence to suggest 
that pregnancy rates vary by timing of IUD insertion [4,5,10]. Despite large sample sizes in 
these studies, pregnancy rate estimates are based on small numbers of pregnancies. In 
addition, given the assignment to IUD insertion on certain cycle days was not randomized, it 
is possible that clinicians may have chosen to insert IUDs mid-cycle only in women they 
were confident were not pregnant [10].
Four studies examined the effects of timing of IUD insertion on pain immediately or soon 
after insertion and found little evidence for an association. One small study reported that the 
pain index was positively correlated with the day of the cycle on which the IUD was 
inserted, but no further details were presented [6]. Another small study reported that pain 
immediately following IUD insertion was independent of day of cycle [7], but actual results 
were not presented. A subgroup analysis of women enrolled in a clinical trial of prophylactic 
ibuprofen at IUD insertion found pain scores after insertion were highest among those with 
insertions <6 days or ≥11 days since the start of last menstrual period and lowest among 
those with insertions 6–10 days since the start of last menstrual period [8]. However, the 
absolute pain scores were quite low and the clinical significance of small differences in pain 
score is unclear. Additionally, as a subgroup analysis, the study was not powered to examine 
differences by timing of insertion; less than 5% of insertions occurred 6 days or more after 
the start of the last menstrual cycle.
Another study also examined immediate expulsion and bleeding at insertion. This large 
cross-sectional analysis reported pain was more common among those with insertions 
outside menses than during menses and rates of bleeding were similar, although no direct 
statistical comparisons were made and the absolute rates of pain and bleeding were very low 
[4]. In addition, this study reported that immediate expulsion was more common among 
those with insertions during menses than those with insertions outside of menses; a 
statistical comparison of the occurrence of immediate expulsion that included a third group 
of women with oligomenorrhea/amenorrhea was statistically significant. However, the odds 
ratio comparing the odds of any IUD insertion problem among those with insertions outside 
versus within menses was non-significant.
Ensuring a woman is not pregnant is an important issue to consider when making 
recommendations regarding when during the menstrual cycle a woman can start IUD use. 
Thus, it is important to consider conception probabilities by cycle day in the absence of 
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contraceptive use. Information on day-specific estimates of conception come from a 
prospective study in which estimated day of ovulation was estimated for 696 cycles from 
221 women attempting to conceive who collected daily urine samples and recorded days 
during which intercourse and menstrual bleeding occurred [12,13]. Only 2% of women had 
entered the fertile window (the five days before ovulation and the day of ovulation itself) by 
Cycle Day 4 and 17% by Cycle Day 7 [12]. By Days 12 and 13, 54% of women had entered 
the fertile window. When examining the probability of clinical pregnancy from a single act 
of intercourse, daily probabilities ranged from 0.4% on Day 5 and 1.7% by Cycle Day 7, to a 
peak of 9% on Cycle Day 13, with a steep decline thereafter [13]. Women with irregular 
cycles generally had later and more irregular ovulation, with the peak probability of clinical 
pregnancy occurring later in the cycle. It is also worth noting the emergency contraceptive 
effect of the Cu-IUD; the Cu-IUD can be inserted within five days of unprotected 
intercourse to prevent pregnancy [14,15].
We did not identify any studies regarding the effects of insertion of the LNG-IUD at 
different times during the menstrual cycle. According to manufacturer insertion instructions, 
the LNG-IUD can be inserted within seven days of the onset of menstruation or immediately 
after a first trimester abortion and device replacement can occur at any time during the 
menstrual cycle (Bayer HealthCare Pharmaceuticals). Unlike the Cu-IUD, the use of the 
LNG-IUD as an emergency contraceptive has not been studied and is not recommended 
[15]. It should also be noted that pregnancy during LNG-IUD use carries different clinical 
concerns because of theoretical concerns that in the event of pregnancy, there may be added 
risks to the fetus due to hormonal exposure.
In summary, there is fair evidence indicating that insertion of Cu-IUD at different times of 
the menstrual cycle has little effect on contraceptive safety, continuation or effectiveness. 
The studies included in this systematic review were limited by small sample sizes for 
insertions performed during later days of the menstrual cycle and non-randomized 
assignment to timing of insertion (body of evidence grading: II-2, fair).
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